Skip to content
Screener

Century Therapeutics IPSC Q1 2025 earnings

Reported May 15, 2025 · Before market open

Revenue$109.2MBeat by $67.9M
EPS$0.89Beat by $1.20
Revenue estimate$41.3M
EPS estimate-$0.31

Next report

Nov 12, 2026 (in 2 months)
Revenue estimate$1.6M
EPS estimate-$0.12

Versus estimates

Revenue

Q1 2025$109.2MBeat by $67.9M

Diluted EPS

Q2 2026-$0.17Miss by $0.06Q1 2026-$0.11Beat by $0.04Q4 2025-$0.25Beat by $0.03Q3 2025-$0.32Beat by $0.07Q2 2025-$0.38In line
Q1 2025$0.89Beat by $1.20

FAQ

When did Century Therapeutics report Q1 2025 earnings?
Century Therapeutics (IPSC) reported Q1 2025 earnings on May 15, 2025 before market open.
What were Century Therapeutics's Q1 2025 revenue and EPS?
Century Therapeutics reported revenue of $109.2M and eps of $0.89 for Q1 2025.
Did Century Therapeutics beat estimates in Q1 2025?
Revenue beat the consensus estimate of $41.3M by $67.9M. EPS beat the consensus estimate of $-0.31 by $1.20.
How did Century Therapeutics's Q1 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 12667.7% from $855.0K a year earlier.
Where can I find Century Therapeutics's Q1 2025 SEC filings?
You can read the 8-K earnings release (0001104659-25-049454) and the 10-Q periodic report (0001558370-25-007885) directly on SEC EDGAR. The filing index links above go to sec.gov.